E Rychnavská

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The objective was to investigate the tolerance of ethophylline clofibrate (EPC) and its effectiveness on changes of dyslipidaemia and compensation of diabetes in type II diabetics during six-month administration of the preparation Duolip forte (Merckle). Twenty diabetics with dyslipoproteinaemia IIb and IV according to Frederickson's classification,(More)
  • 1